(RD16/0012/0009). FG is a recipient of a Sara Borrell postdoctoral fellowship from ISCII (CD15/00095). RL-M is supported by a "Miguel Servet tipo-I" contract from ISCIII (CP16/00033). BU is supported by funds from the RETICS Program (RIER) (RD12/0009/0013) from ISCIII (Health Ministry, Spain Rheumatology and Immunology, the Second Xiang Ya Hospital, Central South University, Changsha, Hunan, China, Changsha, China Background: Mounting studies have illustrated an important role of autophagy in various diseases, but few studies have reported its contribution to rheumatoid arthritis (RA) and the underlying mechanism is largely unknown. Objectives: This study aimed to investigate whether autophagy inhibitors could regulate apoptosis and proliferation through PI3K/AKT pathway in RA. Methods: RA animal model was established by collagen induction. General observations and degree of joint swelling were observed. Inflammatory response, cell survival related factors and apoptosis were also detected in synovial fibroblasts. In addition, cultured rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) were subjected to TNF-α treatment in vitro, and TNF-α induced cell autophagy, synovial cell proliferation and apoptosis were detected. Moreover, cell cycle and cytokine secretion protein, along with the above parameters, were analyzed.
Results:
Results from the animal model showed that autophagy inhibitors could attenuate inflammatory reaction and synovial hyperplasia, while promoted synovial fibroblasts apoptosis. Meanwhile, inhibition of autophagy promoted cell apoptosis and reversed cell proliferation in vitro, also blocked cell in the G2/M arrest and reduced the S phase cells. Furthermore, inhibition of PI3K/AKT pathway reversed TNF-α mediated autophagy and cytokine secretion. Background: DBA/1 mouse (H2 q type) CIA model as a mature model of rheumatoid arthritis is widely used in pharmacology and pharmacodynamics research [1] . Chinese medicine treatment of rheumatoid arthritis has accumulated rich experience. The study of Tripterygium glycosides is quite representative, and it has been widely used in the past 30 years. Some Clinical studies showed that tripterygium glycosides treatment of rheumatoid arthritis had good effect [2] . ChuanTengTongBi decoction is also the effective prescription commonly used for the treatment of rheumatoid arthritis. Objectives: To investigate the pathological damage degree of DBA/1 mouse CIA model and the effects of different doses of ChuanTengTongBi decoction on the CIA model mice. Methods: The mice were divided into normal group, model group, leflunomide group (3.11mg/kg/d), low-dose of ChuanTengTongBi group (0.44g/ml/d), mediumdose group (0.88g/ml/d) and high-dose group (1.76g/ml/d).
The arthritis index (AI) was evaluated every week to determine whether the model was successful. We defined AI score ≥4 as successful model (AI score
